AB

Ashis Bajpayee

Active Director Managing Director DIN 11506727
DIN 11506727 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashis Bajpayee

Data last updated:

Ashis Bajpayee is a Managing Director at Trinity Global Private Limited (since 2026) and Director at Medwest Pharma Private Limited (since 2026).

DIN 11506727
Primary Designation Managing Director
First Appointment 27 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trinity Global Private Limited U30911WB2026PTC286981
Managing Director10 Feb 20262026Active
Medwest Pharma Private Limited U21001WB2026PTC286475
Director27 Jan 20262026Active

Board colleagues of Ashis Bajpayee

Directorship timeline

Open interactive timeline →
Medwest Pharma Private Limited
Trinity Global Private Limited
Premium access

Shareholding and investment profile for Ashis Bajpayee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashis Bajpayee

Ashis Bajpayee currently holds 2 directorships: Trinity Global Private Limited (Managing Director, since 10 Feb 2026); Medwest Pharma Private Limited (Director, since 27 Jan 2026).

Ashis Bajpayee was first appointed on 27 Jan 2026 as Director at Medwest Pharma Private Limited.

The current boards of Ashis Bajpayee's companies include Rajani Rudra (Trinity Global Private Limited), Suman Roy Choudhury (Trinity Global Private Limited), Sushama Paul (Medwest Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available